Brochures

Finally tackle your most challenging affinity screenings with breakthrough Spectral Shift technology

Issue link: https://resources.nanotempertech.com/i/1462516

Contents of this Issue

Navigation

Page 5 of 10

Don't give up just yet when challenging molecules like these enter your pipeline Armed with Dianthus, you have an opportunity to remove the roadblocks you encounter when your hit identification or lead optimization involves any of these molecules. PROTACs and other protein degraders Measuring affinities with small molecules, like warheads, requires a lot of assay development if your method relies on significant mass changes to detect a binding event. And studying the ternary complex gets complicated if immobilization of the secondary complex is required. With Dianthus, measurements are done in solution and are mass-independent — just what your PROTAC screening project needs. Intrinsically disordered proteins (IDPs) Dianthus measures in solution, so the conformational equilibrium of your IDPs is not at risk of being disrupted — a common problem with methods that require immobilization. And because Dianthus uses low target concentrations, aggregation of the IDPs won't get in the way of screening for binders. Fragment libraries Because fragments are really tiny, identifying hits from fragment libraries is very difficult with screening methods that depend on considerable mass changes. Additionally, you're challenged with measuring weak affinities during hit identification and tighter affinities when fragments are grown to form larger compounds. Dianthus overcomes both issues with mass-independent measurements and an ability to detect a broad range of affinities.

Articles in this issue

view archives of Brochures - Finally tackle your most challenging affinity screenings with breakthrough Spectral Shift technology